跳至主要内容
临床试验/NCT02784145
NCT02784145已完成不适用

Effects of Resistant Starch on Bowel Habits, Fecal Short Chain Fatty Acids and Gut Microbiota in Parkinson Disease

Universität des Saarlandes2 个研究点 分布在 1 个国家目标入组 95 人开始时间: 2016年5月最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
入组人数
95
试验地点
2
主要终点
Bowel habits

研究概览

简要总结

The investigators will investigate the effects of an 8-week resistant starch (RS) supplementation (5 g twice a day) in patients with Parkinson Disease and matched controls on:

  1. symptoms of constipation (assessed by clinical scores);
  2. fecal short chain fatty acid concentrations (measured by chromatography);
  3. gut microbiota composition.

研究设计

研究类型
Interventional
分配方式
Non Randomized
干预模型
Parallel
主要目的
Other
盲法
None

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Written informed to participate
  • For patients: diagnosis of Parkinson Disease

排除标准

  • Use of antibiotics, steroids or probiotic supplements
  • Chronic or acute disorders of the gastrointestinal tract
  • History of gastrointestinal surgery (other than appendectomy)
  • For healthy controls: Family history of neurodegenerative disorders

结局指标

主要结局

Bowel habits

时间窗: 8 weeks

Number of patients with improved bowel habits

Fecal short chain fatty acid (SCFA) concentrations

时间窗: 8 weeks

Number of patients with either a) increased, b.) unaltered or c) decreased concentration of short chain fatty acids in fecal samples at 8 weeks (compared to baseline)

Analysis of fecal microbiota composition

时间窗: 8 weeks

Analysis to detect changes between baseline and 8 weeks of resistant starch supplementation

次要结局

未报告次要终点

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Dr. Marcus Unger

PD Dr.

Universität des Saarlandes

研究点 (2)

Loading locations...

相似试验

Effects of Resistant Starch on Bowel Habits, Fecal... | 临床试验